Research articles
Longer reads on how specific peptides work, how stable they are, and what the evidence does and does not show.
-
Mechanism of Action of Tirzepatide: A Technical Deep Dive into Dual GIP/GLP-1 Receptor Agonism
Pathway
Tirzepatide is a first-in-class dual agonist that simultaneously activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (
-
Semaglutide and the Gut-Brain Axis: How GLP-1 Signaling Controls Appetite and Satiety
Pathway
Semaglutide controls appetite through dual gut-brain axis pathways: peripheral GLP-1 receptors on vagal afferent neurons transmit satiety signals to the brainst
-
Ipamorelin and Growth Hormone Secretagogue Signaling: GHS-R1a Pathway Deep Dive
Pathway
Ipamorelin selectively activates the growth hormone secretagogue receptor type 1a (GHS-R1a) to stimulate pituitary growth hormone release without the off-target
-
MOTS-c: The Mitochondrial-Derived Peptide That Mimics Exercise
Pathway
MOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome's 12S rRNA gene, representing a novel class of 'mitokines', signaling molecules derived
-
How BPC-157 Triggers New Blood Vessels (VEGF)
Pathway
BPC-157 triggers new blood vessel formation mainly at the receptor end of the VEGF axis: in ischemic rat hind-limb muscle and human endothelial cells it raised
-
FOXO4-DRI: Senolytic Peptide Mechanism and the p53-FOXO4 Axis
Pathway
FOXO4-DRI is a D-retro-inverso peptide that selectively kills senescent cells by disrupting the protective FOXO4-p53 interaction. In senescent cells, FOXO4 bind
-
How GHK-Cu Binds Copper and Changes Gene Expression
Pathway
GHK-Cu binds copper(II) in a stable 1:1 complex (glycyl-L-histidyl-L-lysine:copper) and thereby modulates expression of over 4,000 genes, about 32% of the huma
-
Semax and BDNF: Neurotrophin Signaling and Cognitive Enhancement Mechanisms
Pathway
Semax enhances cognitive function primarily through upregulation of BDNF (brain-derived neurotrophic factor) and activation of TrkB receptor signaling in the br
-
Sermorelin Pharmacology: GHRH Receptor Binding, Pituitary Signaling, and Physiological Growth Hormone Restoration
Pathway
Sermorelin is a synthetic 29-amino acid peptide corresponding to the N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-44). It binds the GHR